BackLifecore Biomedical Overview

Lifecore Biomedical Long Term Debt

Latest long-term debt for LFCR: $150M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$148.80M

Peer average

Loading

Lifecore Biomedical Long Term Debt History

Loading

Lifecore Biomedical vs. peers: Long Term Debt Comparison

Loading

Lifecore Biomedical Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Lifecore Biomedical (LFCR) FAQ

Lifecore Biomedical (LFCR) currently reports a long-term debt of $150M as of March 2026. Use the charts on this page to explore Lifecore Biomedical's long-term debt history and peer comparisons.

Lifecore Biomedical reported $150M in long-term debt as of March 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $150M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lifecore Biomedical, and consider following LFCR for alerts when major investors trade the stock.

Lifecore Biomedical is classified in the Materials sector. On long-term debt, it currently shows $150M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing LFCR with unrelated industries.